Spatial access inequities and childhood immunisation uptake in Kenya.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
15 Sep 2020
Historique:
received: 25 02 2020
accepted: 31 08 2020
entrez: 16 9 2020
pubmed: 17 9 2020
medline: 15 5 2021
Statut: epublish

Résumé

Poor access to immunisation services remains a major barrier to achieving equity and expanding vaccination coverage in many sub-Saharan African countries. In Kenya, the extent to which spatial access affects immunisation coverage is not well understood. The aim of this study was to quantify spatial accessibility to immunising health facilities and determine its influence on immunisation uptake in Kenya while controlling for potential confounders. Spatial databases of immunising facilities, road network, land use and elevation were used within a cost friction algorithim to estimate the travel time to immunising health facilities. Two travel scenarios were evaluated; (1) Walking only and (2) Optimistic scenario combining walking and motorized transport. Mean travel time to health facilities and proportions of the total population living within 1-h to the nearest immunising health facility were computed. Data from a nationally representative cross-sectional survey (KDHS 2014), was used to estimate the effect of mean travel time at survey cluster units for both fully immunised status and third dose of diphtheria-tetanus-pertussis (DPT3) vaccine using multi-level logistic regression models. Nationally, the mean travel time to immunising health facilities was 63 and 40 min using the walking and the optimistic travel scenarios respectively. Seventy five percent of the total population were within one-hour of walking to an immunising health facility while 93% were within one-hour considering the optimistic scenario. There were substantial variations across the country with 62%(29/47) and 34%(16/47) of the counties with < 90% of the population within one-hour from an immunising health facility using scenarios 1 and 2 respectively. Travel times > 1-h were significantly associated with low immunisation coverage in the univariate analysis for both fully immunised status and DPT3 vaccine. Children living more than 2-h were significantly less likely to be fully immunised [AOR:0.56(0.33-0.94) and receive DPT3 [AOR:0.51(0.21-0.92) after controlling for household wealth, mother's highest education level, parity and urban/rural residence. Travel time to immunising health facilities is a barrier to uptake of childhood vaccines in regions with suboptimal accessibility (> 2-h). Strategies that address access barriers in the hardest to reach communities are needed to enhance equitable access to immunisation services in Kenya.

Sections du résumé

BACKGROUND BACKGROUND
Poor access to immunisation services remains a major barrier to achieving equity and expanding vaccination coverage in many sub-Saharan African countries. In Kenya, the extent to which spatial access affects immunisation coverage is not well understood. The aim of this study was to quantify spatial accessibility to immunising health facilities and determine its influence on immunisation uptake in Kenya while controlling for potential confounders.
METHODS METHODS
Spatial databases of immunising facilities, road network, land use and elevation were used within a cost friction algorithim to estimate the travel time to immunising health facilities. Two travel scenarios were evaluated; (1) Walking only and (2) Optimistic scenario combining walking and motorized transport. Mean travel time to health facilities and proportions of the total population living within 1-h to the nearest immunising health facility were computed. Data from a nationally representative cross-sectional survey (KDHS 2014), was used to estimate the effect of mean travel time at survey cluster units for both fully immunised status and third dose of diphtheria-tetanus-pertussis (DPT3) vaccine using multi-level logistic regression models.
RESULTS RESULTS
Nationally, the mean travel time to immunising health facilities was 63 and 40 min using the walking and the optimistic travel scenarios respectively. Seventy five percent of the total population were within one-hour of walking to an immunising health facility while 93% were within one-hour considering the optimistic scenario. There were substantial variations across the country with 62%(29/47) and 34%(16/47) of the counties with < 90% of the population within one-hour from an immunising health facility using scenarios 1 and 2 respectively. Travel times > 1-h were significantly associated with low immunisation coverage in the univariate analysis for both fully immunised status and DPT3 vaccine. Children living more than 2-h were significantly less likely to be fully immunised [AOR:0.56(0.33-0.94) and receive DPT3 [AOR:0.51(0.21-0.92) after controlling for household wealth, mother's highest education level, parity and urban/rural residence.
CONCLUSION CONCLUSIONS
Travel time to immunising health facilities is a barrier to uptake of childhood vaccines in regions with suboptimal accessibility (> 2-h). Strategies that address access barriers in the hardest to reach communities are needed to enhance equitable access to immunisation services in Kenya.

Identifiants

pubmed: 32933501
doi: 10.1186/s12889-020-09486-8
pii: 10.1186/s12889-020-09486-8
pmc: PMC7493983
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1407

Subventions

Organisme : Wellcome Trust
ID : 201866/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203077
Pays : United Kingdom
Organisme : The DELTAS Africa Intiative
ID : DEL-15-003
Organisme : Wellcome Trust
ID : 201866
Pays : United Kingdom

Références

Bull World Health Organ. 1978;56(2):295-303
pubmed: 96953
BMC Int Health Hum Rights. 2009 Oct 14;9 Suppl 1:S10
pubmed: 19828054
PLoS One. 2015 Aug 28;10(8):e0135222
pubmed: 26317975
Int J Health Geogr. 2012 Jun 27;11:24
pubmed: 22737990
Am J Epidemiol. 2015 Nov 1;182(9):791-8
pubmed: 26453618
Int J Equity Health. 2016 Oct 18;15(1):173
pubmed: 27756374
Afr J Emerg Med. 2020 Mar;10(1):40-45
pubmed: 32161711
JAMA. 2007 Oct 24;298(16):1900-10
pubmed: 17954541
Am J Epidemiol. 2011 Mar 1;173(5):492-8
pubmed: 21262911
PLoS One. 2019 Sep 16;14(9):e0222488
pubmed: 31525226
BMC Int Health Hum Rights. 2009 Oct 14;9 Suppl 1:S13
pubmed: 19828057
Trop Med Int Health. 2006 Feb;11(2):188-96
pubmed: 16451343
Int Health. 2012 Dec;4(4):229-38
pubmed: 24029668
Glob Health Sci Pract. 2019 Mar 13;7(Suppl 1):S151-S167
pubmed: 30867215
Health Econ Rev. 2018 Apr 11;8(1):9
pubmed: 29644503
Asia Pac J Public Health. 2016 Mar;28(2):167-77
pubmed: 26809971
Int J Health Geogr. 2016 Feb 18;15:8
pubmed: 26892310
BMC Health Serv Res. 2015 Nov 04;15:493
pubmed: 26537884
Nat Commun. 2019 Apr 9;10(1):1633
pubmed: 30967543
BMC Public Health. 2006 May 17;6:132
pubmed: 16707013
Malar J. 2016 Mar 22;15:179
pubmed: 27006074
Int J Equity Health. 2015 Feb 27;14:24
pubmed: 25889450
J Epidemiol Community Health. 2018 Aug;72(8):719-725
pubmed: 29581228
BMC Public Health. 2012 Jun 22;12:476
pubmed: 22726457
BMC Pregnancy Childbirth. 2016 Aug 22;16:240
pubmed: 27549156
Sci Data. 2019 Jul 25;6(1):134
pubmed: 31346183
Vaccine. 2010 Aug 9;28(35):5725-30
pubmed: 20600489
Asia Pac J Public Health. 2019 Jan;31(1):51-60
pubmed: 30499306
Int J Health Geogr. 2015 May 27;14:19
pubmed: 26014352
BMC Public Health. 2017 Jun 8;17(1):556
pubmed: 28595624
PLoS One. 2015 Feb 17;10(2):e0107042
pubmed: 25689585
Int J Health Geogr. 2011 Jul 25;10:44
pubmed: 21787394
PLoS One. 2012;7(5):e37905
pubmed: 22662247
Int J Health Geogr. 2017 Jan 13;16(1):1
pubmed: 28086893
Int J Health Geogr. 2008 Dec 16;7:63
pubmed: 19087277
Malar J. 2017 Sep 12;16(1):367
pubmed: 28899379
J Glob Health. 2018 Dec;8(2):020404
pubmed: 30023051
Vaccine. 2011 Oct 26;29(46):8215-21
pubmed: 21893149

Auteurs

Noel K Joseph (NK)

Population Health Unit, Kenya Medical Research Institute-Wellcome Trust Research Programme, Nairobi, Kenya. NJoseph@kemri-wellcome.org.

Peter M Macharia (PM)

Population Health Unit, Kenya Medical Research Institute-Wellcome Trust Research Programme, Nairobi, Kenya.

Paul O Ouma (PO)

Population Health Unit, Kenya Medical Research Institute-Wellcome Trust Research Programme, Nairobi, Kenya.

Jeremiah Mumo (J)

Health Information System Unit, Ministry of Health, Nairobi, Kenya.

Rose Jalang'o (R)

National Vaccines and Immunization Programme, Ministry of Health, Nairobi, Kenya.

Peter W Wagacha (PW)

School of Computing and Informatics, University of Nairobi, Nairobi, Kenya.

Victor O Achieng (VO)

Kenya Country Office, The United Nations Children's Fund, Nairobi, Kenya.

Eunice Ndung'u (E)

Kenya Country Office, The United Nations Children's Fund, Nairobi, Kenya.

Peter Okoth (P)

Kenya Country Office, The United Nations Children's Fund, Nairobi, Kenya.

Maria Muñiz (M)

Regional Office for Eastern and Southern Africa, The United Nations Children's Fund, Nairobi, Kenya.

Yaniss Guigoz (Y)

GeoHealth group, Institute of Global Health & Institute for Environmental Sciences, University of Geneva, Geneva, Switzerland.

Rocco Panciera (R)

Health section, The United Nations Children's Fund, New York, USA.

Nicolas Ray (N)

GeoHealth group, Institute of Global Health & Institute for Environmental Sciences, University of Geneva, Geneva, Switzerland.

Emelda A Okiro (EA)

Population Health Unit, Kenya Medical Research Institute-Wellcome Trust Research Programme, Nairobi, Kenya.
Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7LJ, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH